Diruthenium (II,III)-ketoprofen anticancer metallodrug investigated for interaction with transferrin and for effects on the antiproliferative activity, apoptotic and mitotic processes in the A172 human glioma cell line (2016)
- Authors:
- USP affiliated authors: COLQUHOUN, ALISON - ICB ; SILVA, DENISE DE OLIVEIRA - IQ
- Unidades: ICB; IQ
- Subjects: GLIOMA; RUTÊNIO
- Language: Inglês
- Imprenta:
- Publisher: Sociedade Brasileira de Química-SBQ
- Publisher place: São Paulo
- Date published: 2016
- Source:
- Título: Resumos
- Conference titles: Brazilian Meeting on Inorganic Chemistry-BMIC
-
ABNT
SANCHES, Rute Nazaré Fernandes et al. Diruthenium (II,III)-ketoprofen anticancer metallodrug investigated for interaction with transferrin and for effects on the antiproliferative activity, apoptotic and mitotic processes in the A172 human glioma cell line. 2016, Anais.. São Paulo: Sociedade Brasileira de Química-SBQ, 2016. Disponível em: http://bmic2016.iqm.unicamp.br. Acesso em: 16 out. 2024. -
APA
Sanches, R. N. F., Freitas, T. E., Colquhoun, A., & Denise de Oliveira Silva,. (2016). Diruthenium (II,III)-ketoprofen anticancer metallodrug investigated for interaction with transferrin and for effects on the antiproliferative activity, apoptotic and mitotic processes in the A172 human glioma cell line. In Resumos. São Paulo: Sociedade Brasileira de Química-SBQ. Recuperado de http://bmic2016.iqm.unicamp.br -
NLM
Sanches RNF, Freitas TE, Colquhoun A, Denise de Oliveira Silva. Diruthenium (II,III)-ketoprofen anticancer metallodrug investigated for interaction with transferrin and for effects on the antiproliferative activity, apoptotic and mitotic processes in the A172 human glioma cell line [Internet]. Resumos. 2016 ;[citado 2024 out. 16 ] Available from: http://bmic2016.iqm.unicamp.br -
Vancouver
Sanches RNF, Freitas TE, Colquhoun A, Denise de Oliveira Silva. Diruthenium (II,III)-ketoprofen anticancer metallodrug investigated for interaction with transferrin and for effects on the antiproliferative activity, apoptotic and mitotic processes in the A172 human glioma cell line [Internet]. Resumos. 2016 ;[citado 2024 out. 16 ] Available from: http://bmic2016.iqm.unicamp.br - The novel ruthenium—γ-linolenic complex [Ru2(aGLA)4Cl] inhibits C6 rat glioma cell proliferation and induces changes in mitochondrial membrane potential, increased reactive oxygen species generation and apoptosis in vitro
- Time-dependent effects of a novel ruthenium complex containing the non-steroidal anti-inflammatory drug (NSAID) ibuprofen on the mRNA expression of proteins involved in cell cycle control, angiogenesis and invasion in C6 rat glioma cells In vitro
- Diruthenium(II,III)-non-steroidal anti-inflammatory drug complexes and their effects on tumor-cell proliferation
- Anti-tumour properties of novel ruthenium complexes containing non-steroidal anti-inflamatory drugs (NSAIDs)
- Inhibition of C6 rat glioma proliferation by ['RU IND. 2''CL''(ibp) IND. 4'] depends on changes in p21, p27, Bax/Bcl2 ratio and mitochondrial membrane potential
- Diruthenium(II, III) complexes of ibuprofen, aspirin, naproxen and indomethacin non-steroidal anti-inflammatory drugs: synthesis, characterization and their effects on tumor-cell proliferation
- Axially-modified paddlewheel diruthenium(II,III)-ibuprofenato metallodrugs and the influence of the structural modification on U87MG and A172 human glioma cell proliferation, apoptosis, mitosis and migration
- Synthesis and characterization of new diruthenium (II, III) complexes with non-steroidal anti-inflammatory drugs
- Growth inhibitory effects of the diruthenium-ibuprofen compound, 'RU IND. 2''CL'(Ibp)' IND. 4', in human glioma cells in vitro and in the rat C6 orthotopic glioma in vivo
- Time-dependent effects of a novel ruthenium complex containing the non-steroidal anti-inflammatory drug (NSAID) ibuprofen on the mRNA expression of proteins involved in cell cycle control, angiogenesis and invasion in C6 rat glioma cells in vitro
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
